<DOC>
	<DOC>NCT00567385</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to evaluate the acceptance of the new liquid growth hormone formulation, somatropin, in children with growth hormone deficiency.</brief_summary>
	<brief_title>Liquid Somatropin Formulation in Children With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Growth failure due to growth hormone insufficiency (GHD) Turner syndrome: established diagnosis according to sex chromosome analysis, or Growth retardation in children with chronic renal disorders Pregnancy Breast feeding women Suspected or know allergy to trial product Participating in any other trial involving other investigational products within the last 3 months Previous participation in the trial Other daily injection therapy (nongrowth hormone, e.g insulintherapy)</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>